dockets: FDA-2022-E-2011
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-E-2011 | FDA | Patent Extension Application for LYBALVI® (olanzapine and samidorphan), Patent No. 9,126,977 | Nonrulemaking | 2025-01-27T11:59:11Z | 0b00006485273d39 | list_pull |
Links from other tables
- 7 rows from docket_id in documents